Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2005-05-17
2005-05-17
Horlick, Kenneth R. (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S006120, C435S091100, C536S023100, C536S024300, C536S024330, C536S025300
Reexamination Certificate
active
06893846
ABSTRACT:
Oliognucleotide primers are provided that are specific for nucleic acid characteristic of certain beta-lactamases. The primers can be employed in methods to identify nucleic acid characteristic of family-specific beta-lactamase enzymes in samples, and particularly, in clinical isolates of Gram-negative bacteria.
REFERENCES:
patent: 4683194 (1987-07-01), Saiki et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 5994066 (1999-11-01), Bergeron et al.
patent: 6001564 (1999-12-01), Bergeron et al.
patent: 6242223 (2001-06-01), Hanson et al.
patent: WO 9108305 (1991-06-01), None
Arlet al., Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable beta-lactamases (TEM, SHV, CARB). FEMS Microbiology Letter, 82, 19-26, 1991.*
Alksne et al., “Expression of the AsbA1, OXA-12, and AsbM1 β-Lactamases inAeromonas jandaeiAER 14 IS Coordinated by a Two-Component Regulon,”Journal of Bacteriology, 179(6):2006-2013 (1997).*
Daniel et al., “OXA-15, an Extended-Spectrum Variant of OXA-2 β-Lactamase, Isolated from aPseudomonas aeruginosaStrain,”Antimicrobial Agents and Chemotherapy, 41(4):785-790 (1997).*
Rasmussen et al., “Cloning and Expression of a Cloxacillin-Hydrolyzing Enzyme and a Cephalosporinase fromAeromonas sobriaAER 14M inEscherichia coli:Requirement for anE. coliChromosomal Mutation for Efficient Expression of the Class D Enzyme,”Antimicrobial Agents and Chemotherapy,38(9):2078-2085 (1994).*
Scoulica et al., “Molecular Characterization of the OXA-7 β-Lactamase Gene,”Antimicrobial Agents and Chemotherapy, 39(6):1379-1382 (1995).*
Tolmasky et al., “Genetic Organization Antibiotic Resistant Genes (aac(6′)-Ib, aadA. and OXA-9) in the Multiresistance Transposon TnI33I,”Plasmid, 29:31-40 (1993).*
Acar et al., “Nature of the Resistance Problem,”Clin. Inf. Dis., 24(Suppl 1):S1 (1997).
Arlet et al., “Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB),”FEMS Microbiol. Lett., 82:19-25 (1991).
Arlet et al., “Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases,”FEMS Microbiol Lett., 134:203-208 (1995).
Arlet et al., “Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum β-lactamase,”FEMS Microbiol Lett., 152:163-167 (1997).
Barnaud et al., “Cloning and sequencing of the gene encoding the AmpC β-lactamase ofMorganella morganii,” FEMS Microbiol Lett., 148:15-20 (1997).
Bauernfeind et al., “A New Plasmidic Cefotaximase in a Clinical Isolate ofEscherichia coli,” Infection, 18(5):294-298 (1990).
Billot-Klein et al., “Nucleotide Sequence of the SHV-5 β-Lactamase Gene of aKlebsiella pneumoniaPlasmid,”Antimicrob. Agents Chemother., 34(12):2439-2441 (1990).
Birnboim et al., “A rapid alkaline extraction procedure for screening recombinant plasmid DNA,”Nucleic Acids Res., 7(6):1513-1523 (1979).
Bradford et al., “SHV-7, a Novel Cefotaxime-Hydrolyzing β-Lactamase, Identified inEscherichia coliIsolates from Hospitalized Nursing Home Patients,”Antimicrob. Agents Chemother., 39(4):899-905 (1995).
Bradford et al., “Multiply ResistantKlebsiella pneumoniaeStrains from Two Chicago Hospitals: Identification of the Extended-Spectrum TEM-12 and TEM-10 Ceftazidime-Hydrolyzing β-Lactamases in a Single Isolate,”Antimicrob. Agents Chemother., 38(4): 761-766 (1994).
Bret et al., “Chromosomally Encoded AmpC-Type β-Lactamase in a Clinical Isolate ofProteus mirabilis,” Antimicrob. Agents Chemother., 42(5):1110-1114 (1998).
Brun-Buisson et al., “Transferable Enzymatic Resistance to Third-Generation Cephalosporins During Nosocomial Outbreak of Multiresistant Klebsiella Pneumoniae,”The Lancet, 2:302-306 (1987).
Burns et al., “An Integrated Nanoliter DNA Analysis Device,”Science, 282:484-487 (1998).
Canica et al., “Molecular Diversity and Evolution of blatemGenes Encoding β-Lactamases Resistant to Clavulanic Acid in ClinicalE. coli,” J. Mol. Evol., 44:57-65 (1997).
Carter et al., “Use of a non-radioactive hybridisation assay for direct detection of gram-negative bacteria carrying TEM β-lactamase genes in infected urine,”J. Med. Microbiol, 28:113-117 (1989).
Check, “Clinical Microbiology Eyes Nucleic Acid-Based Technologies,”ASM News, 64(2):84-89 (1998).
Crea et al., “Chemical synthesis of genes for human insulin,”Proc. Natl. Acad. Sci. USA, 75(12):5765-5769 (1978).
Crosa et al., “Plasmids,”Manual of Methods for General Bacteriology,Gerhardt et al., eds., American Society for Microbiology, Washington, DC, Ch. 15, pp. 266-282 (1981).
Curran et al., “A rapid immunoassay method for the direct detection of PCR products: application to detection of TEM β-lactamase genes,”J. Med. Microbiol., 45:76-78 (1996).
Galleni et al., “Sequence and comparative analysis of threeEnterobacter cloacae ampC β-lactamase genes and their products,”Biochem. J., 250,753-760 (1988).
Gold et al., “Antimicrobial-Drug Resistance,”The New England Journal of Medicine, 335(19):1445-1453 (1996).
Gonzalez Leiza et al., “Gene sequence and biochemical characterization of FOX-1 fromKlebsiella pneumoniae,a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants,”Antimicrob. Agents Chemother., 38(9):2150-7 (1994).
Hanson et al., “Molecular Characterization of a Multiply ResistantKlebsiella pneumoniae,” Abstract C-59,37thICAAC,Toronto, Ontario, Canada, Sep. 28-Oct. 1 (1997).
Hanson et al., “A Novel TEM-Type Extended Spectrum Beta-Lactamase Expressed in Three Different Genera of Enterobacteriaceae from South Africa,” Abstract C-5, p. 70,38thICAAC,San Diego, California, Sep. 24-27 (1998).
Hanson et al., “Molecular characterization of a multiply resistantKlebsiella pneumoniaeencoding ESBLs and a plasmid-mediated AmpC,”J. Antimicrob. Chemother., 44:377-380 (1999).
Hanson et al., “Regulation of Inducible AmpC Beta-Lactamase Expression Among Enterobacteriaceae,”Curr. Pharmac. Design, 5(11):881-894 (1999).
Hibbert-Rogers et al., “Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity,”J. Antimicrob. Chemother., 33:707-720 (1994).
Huletsky et al., “Nucleotide Sequence and Phylogeny of SHV-2 β-Lactamase,”Antimicrob. Agents Chemother., 34(9):1725-1732 (1990).
Jacoby et al., “More Extended-Spectrum β-Lactamases,”Antimicrob. Agents Chemother., 35(9):1697-1704 (1991).
Jarlier et al., “Extended Broad-Spectrum β-Lactamases Conferring Transferable Resistance to Newer β-Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility Patterns,”Rev. Infect. Dis., 10(4):867-878 (1988).
Jones, “The Emergent Needs for Basic Research, Education, and Surveillance of Antimicrobial Resistance: Problems Facing the Report from the American Society for Microbiology Task Force on Antibiotic Resistance,”Diagn. Microbiol. Infect. Disease, 25:153-161 (1996).
Jones, “Important and Emerging β-Lactamase-mediated Resistances in Hospital based Pathogens: The Amp C Enyzymes,”Diagn. Microbiol. Infect. Dis.,31:461 466 (1998).
Leung et al., “Rarity of transferable β-lactamase production by Klebsiella species,”J. Antimicrob. Chemother., 39:737-745 (1997).
M'Zali et al., “Brief reports: Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP),”J. Antimicrob. Chemother., 37:797-802 (1996).
Mabilat et al., “Direct Sequencing of the Amplified Structural Gene and Promot
Ehrhardt Anton F.
Hanson Nancy D.
Sanders Christine C.
Creighton University
Horlick Kenneth R.
Lu Frank
Mueting Raasch & Gebhardt, P.A.
LandOfFree
Primers for use in detecting beta-lactamases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Primers for use in detecting beta-lactamases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Primers for use in detecting beta-lactamases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3443082